Özkal, Birol http://orcid.org/0000-0002-4056-6936
Övey, İshak Suat http://orcid.org/0000-0002-0392-4386
Article History
Received: 23 August 2019
Accepted: 28 February 2020
First Online: 7 March 2020
Change Date: 31 March 2020
Change Type: Correction
Change Details: The original version of this article unfortunately contained few errors. The dose of sodium selenite was incorrectly indicated as 100 μM in the published version of “Selenium enhances TRPA1 channel-mediated activity of temozolomide in SH-SY5Y neuroblastoma cells”. The correct indication of sodium selenite is 5 µM. Additionally the authors accidenttally referred to reference 11 instead of reference 10 in Group 6.
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author declares that no conflict of interest exists. The authors have no conflicts of interest to disclose.